blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1456403

EP1456403 - METHODS FOR IDENTIFYING COMPOUNDS FOR TREATING CONGESTIVE HEART FAILURE USING HUMAN AMINOPEPTIDASE N [Right-click to bookmark this link]
Former [2004/38]METHODS OF USING 48149, A HUMAN AMINOPEPTIDASE FAMILY MEMBER
[2008/07]
StatusThe application is deemed to be withdrawn
Status updated on  10.07.2009
Database last updated on 03.09.2024
Most recent event   Tooltip10.07.2009Application deemed to be withdrawnpublished on 12.08.2009  [2009/33]
Applicant(s)For all designated states
MILLENNIUM PHARMACEUTICALS, INC.
75 Sidney Street Cambridge
Massachusetts 02139 / US
[N/P]
Former [2004/38]For all designated states
Millennium Pharmaceuticals, Inc.
75 Sidney Street
Cambridge, Massachusetts 02139 / US
Inventor(s)01 / CHUN, Miyoung
88 Country Club Lane
Belmont, MA 02478 / US
 [2004/38]
Representative(s)Spaltmann, Frank, et al
Bayer HealthCare AG
51368 Leverkusen / DE
[N/P]
Former [2006/29]Spaltmann, Frank, et al
Bayer HealthCare AG
51368 Leverkusen / DE
Former [2004/38]Harrison Goddard Foote
Fountain Precinct, Balm Green
Sheffield S1 2JA / GB
Application number, filing date02793843.029.10.2002
[2004/38]
WO2002US34622
Priority number, dateUS20010335084P31.10.2001         Original published format: US 335084 P
[2004/38]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03042358
Date:22.05.2003
Language:EN
[2003/21]
Type: A2 Application without search report 
No.:EP1456403
Date:15.09.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 22.05.2003 takes the place of the publication of the European patent application.
[2004/38]
Search report(s)International search report - published on:US08.07.2004
(Supplementary) European search report - dispatched on:EP31.10.2005
ClassificationIPC:G01N33/573, C12N9/48, A61K38/48, A61K38/55, A61K39/395, A61K31/7088, A61P9/10, C12Q1/37, C12Q1/68
[2005/13]
CPC:
C12N9/48 (EP,US); A61P11/00 (EP); A61P11/06 (EP);
A61P13/12 (EP); A61P3/06 (EP); A61P35/00 (EP);
A61P7/02 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/12 (EP) (-)
Former IPC [2004/38]C12Q1/37, C12Q1/68, C12N9/48
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2004/38]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERFAHREN ZUR IDENTIFIZIERUNG VON VERBINDUNGEN ZUR BEHANDLUNG DES KONGESTIVEN HERZVERSAGEN UNTER VERWENDUNG VON MENSCHLICHEN AMINOPEPTIDASE N[2008/07]
English:METHODS FOR IDENTIFYING COMPOUNDS FOR TREATING CONGESTIVE HEART FAILURE USING HUMAN AMINOPEPTIDASE N[2008/07]
French:METHODES POUR L'IDENTIFICATION DE COMPOSES POUR LE TRAITEMENT DE L'INSUFFISANCE CARDIAQUE CONGESTIVE EN UTILISANT L'AMINOPEPTIDASE N HUMAINE[2008/07]
Former [2004/38]VERFAHREN ZUR VERWENDUNG VON 48149, EINEM MITGLIED DER MENSCHLICHEN AMINOPEPTIDASE-FAMILIE
Former [2004/38]METHODS OF USING 48149, A HUMAN AMINOPEPTIDASE FAMILY MEMBER
Former [2004/38]METHODES D'UTILISATION DE 48149, UN ELEMENT DE LA FAMILLE DE L'AMINOPEPTIDASE HUMAINE
Entry into regional phase09.03.2004National basic fee paid 
09.03.2004Search fee paid 
09.03.2004Designation fee(s) paid 
09.03.2004Examination fee paid 
Examination procedure09.03.2004Amendment by applicant (claims and/or description)
09.03.2004Examination requested  [2004/38]
16.05.2006Despatch of a communication from the examining division (Time limit: M06)
13.11.2006Reply to a communication from the examining division
27.11.2007Date of oral proceedings
22.01.2008Minutes of oral proceedings despatched
10.10.2008Communication of intention to grant the patent
21.02.2009Application deemed to be withdrawn, date of legal effect  [2009/33]
27.03.2009Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2009/33]
Fees paidRenewal fee
25.10.2004Renewal fee patent year 03
27.10.2005Renewal fee patent year 04
31.10.2006Renewal fee patent year 05
31.10.2007Renewal fee patent year 06
22.03.2008Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PX]WO02053170  (INST MEDIZINTECHNOLOGIE MAGDEB [DE], et al) [PX] 1,7-9,11 * claim - *;
 [PX]DE10100052  (INST MEDIZINTECHNOLOGIE MAGDEB [DE]) [PX] 1,7-9,11* the whole document *;
 [E]WO03006646  (BAYER AG [DE], et al) [E] 1,7-9,11 * the whole document *;
 [T]EP1346729  (CARDIOVASCULAR RES INST MAASTR [NL], et al) [T] 1,7-9,11 * the whole document *;
 [X]  - LOJDA Z, "THE IMPORTANCE OF PROTEASE HISTOCHEMISTRY IN PATHOLOGY", HISTOCHEMICAL JOURNAL, (1985), vol. 17, no. 10, ISSN 0018-2214, pages 1063 - 1090, XP008042272 [X] 1,7-9,11 * page 1064, paragraph 2; tables 1,2 * * page 1067, paragraph 5 - page 1068, paragraph 2 * * page 1081, paragraph 3 - page 1082, paragraph 1; figure 4 *

DOI:   http://dx.doi.org/10.1007/BF01002534
 [X]  - PASQUALINI RENATA ET AL, "Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, US, (20000201), vol. 60, no. 3, ISSN 0008-5472, pages 722 - 727, XP002180667 [X] 1,7-9,11 * the whole document *
 [X]  - JOHNSON JASON L ET AL, "Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques", ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, (199811), vol. 18, no. 11, ISSN 1079-5642, pages 1707 - 1715, XP002315869 [X] 1,7-9,11 * the whole document *
 [A]  - SHIMAZAWA R ET AL, "NOVEL SMALL MOLECULE NONPEPTIDE AMINOPEPTIDASE N INHIBITORS WITH A CYCLIC IMIDE SKELETON", JOURNAL OF ENZYME INHIBITION, NEW YORK, NY, US, (1999), vol. 14, no. 4, pages 259 - 275, XP001018772 [A] * the whole document *
 [A]  - NUNEZ LILIANA ET AL, "Cholesterol crystallization-promoting activity of aminopeptidase N isolated from the vesicular carrier of biliary lipids", FEBS (FEDERATION OF EUROPEAN BIOCHEMICAL SOCIETIES) LETTERS, (1993), vol. 329, no. 1-2, ISSN 0014-5793, pages 84 - 88, XP002315840 [A] * the whole document *

DOI:   http://dx.doi.org/10.1016/0014-5793(93)80199-5
 [A]  - LENDECKEL U ET AL, "Role of Alanyl Aminopeptidase in Growth and Function of Human T Cells", INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, SPANDIDOS, ATHENS, GR, (1999), vol. 4, ISSN 1107-3756, pages 17 - 27, XP002977300 [A] 1,7-9,11 * the whole document *
International search[Y]  - PASQUALINI, R ET AL., "Aminopeptidase N is a Receptor for Tumor-Homing Peptides and a Target for Inhibiting Angiogenesis", CANCER RESEARCH, (20000201), vol. 60, pages 722 - 727, XP002180667
 [A]  - LENDECKEL, U. ET AL., "Role of Alanyl Aminopeptidase in Growth and Function of Human T Cells", INT. J. MOLECULAR MEDICINE, (1999), vol. 4, pages 17 - 27, XP002977300
 [A]  - RIEMANN, D. ET AL., "CD-13- Not Just a Marker in Leukemia Typing", IMMUNOLOGY TODAY, (199902), vol. 20, no. 2, pages 83 - 88, XP004157281

DOI:   http://dx.doi.org/10.1016/S0167-5699(98)01398-X
 [Y]  - SAIKI, I. ET AL., "Role of Aminopeptidase N (CD13) in Tumor-Cell Invasion and Extracellular Matrix Degradation", INT. J. CANCER, (1993), vol. 54, pages 137 - 143, XP002977601

DOI:   http://dx.doi.org/10.1002/ijc.2910540122
 [Y]  - FUJII, H. ET AL., "Human Melanoma Invasion and Metastasis Enhancement by High Expression of Aminopeptidase N/CD13", CLIN. EXP. METASTASIS, (1995), vol. 13, pages 337 - 344, XP002977602

DOI:   http://dx.doi.org/10.1007/BF00121910
ExaminationWO02053170
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.